Navigation Links
Genes' 'On/Off' Switches Yield Clues to Breast Cancer
Date:3/24/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, March 23 (HealthDay News) -- Scientists may have developed a new way of predicting when breast cancer will spread.

Two varieties of what scientists call "epigenetic signatures" seem to distinguish more aggressive cancers from less aggressive ones, according to a new study.

Epigenetic alterations do not involve changes to the sequencing of the genes themselves. Instead, they involve alterations in the outer wrapping that holds genes within the chromosome. This chromosomal casing helps determine whether the genes will activate and at what intensity.

Environmental factors, including diet, stress, illness or environmental pollutants can all influence epigenetics, experts note.

The findings could not only lead someday to a new diagnostic screening tool to parse out more aggressive cancers that might benefit from more aggressive treatment, but could also "open the door for new physiological targets" for therapies, explained Dr. Timothy A. Chan, senior author of a paper appearing March 23 in the journal Science Translational Medicine.

It's also not out of the question that modifiable environmental factors might be identified that contribute to the cancers, Chan said.

How to tell if a particular tumor will spread (metastasize), and then finding ways to prevent that are major goals of the researchers. Patients usually die from a cancer that has metastasized, not from localized tumors.

This international consortium of researchers collected a variety of different types of breast cancers -- some were hormone receptor-positive, some negative, some had spread and some had not -- then analyzed their methylation profiles.

Methylation refers to the epigenetic "marks" left on the genome.

"To our surprise, we noted that there appear to be two main epigenomic subgroups," said Chan, who is a lab head and attending physician at Memorial Sloan-Kettering Cancer Center in New York City.

This was a surprise because scientists have identified myriad different types of breast cancers based on their genetics and other characteristics.

In this case, one group showed high methylation and one showed low.

The high-methylation group "tended to be pretty stable at the genomic level and were composed primarily of hormone-positive cancers," Chan said. "The [low-methylation] group includes all the hormone-negative group and about half of hormone-positive cancers."

And women with high-methylation tumors did much better than the other group, independent of their hormone-receptor status.

The team is now working on a test to distinguish the two epigenetic types and are investigating what drives these changes, which have also been observed in colon cancer and the deadly brain cancer glioblastoma.

"What we're probably looking at is some fundamental process that becomes dysregulated and helps drive the cancers," Chan said.

"This [study] allows us to further subset breast cancers into those that are likely to metastasize and those that aren't likely to metastasize, and that's helpful," noted one expert, Dr. Patrick Borgen, chairman of the department of surgery at Maimonides Medical Center in New York City.

But, Borgen cautioned, "the technology that [does this categorization] is far from the grasp of day-to-day clinicians. [The study is] an important foundation for further research."

More information

Learn more about epigenetics at the University of Utah.

SOURCES: Timothy A. Chan, M.D., Ph.D., lab head and attending physician, Memorial Sloan-Kettering Cancer Center, New York City; Patrick Borgen, M.D., chairman, department of surgery, Maimonides Medical Center, New York City; March 23, 2011, Science Translational Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Genes May Affect Severity of Drug Addiction
2. Stupid strategies could be best for the genes
3. New method powerfully boosts efficiency of RNA interference (RNAi) in shutting down genes
4. Ph.D. thesis on 2 genes involved in hereditary breast and ovary cancer cases
5. Kids Rising Obesity Rates Due to Bad Habits, Not Genes: Study
6. All in the family: Lower back disease may be in your genes
7. Contagious cancer thrives in dogs by adopting hosts genes
8. Your Genes Help You Choose Your Friends, Study Says
9. Embryonic stem cells help deliver good genes in a model of inherited blood disorder
10. Ovarian cancer advances when genes are silenced
11. Infidelity Might Be in the Genes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genes' 'On/Off' Switches Yield Clues to Breast Cancer
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than ... the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” ... career as an educator interacting with countless women who had little knowledge of the ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and More”: a ... world hunger, and shares the simple and achievable answer. “The Land of More and ... the Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Next week ... will be repealed by Congressional political games that circumvent health needs of over 30 ... Rally” capture the human anxieties and needs government public servants were suppose to prioritize. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 This report on ... and future scenario of the global market. Large number ... consumption. Severe chronic constipation is a major side effect ... laxatives. Hence, novel targeted therapy has been prescribed to ... launch of targeted medicines, and growing awareness about the ...
(Date:1/19/2017)... NEW YORK , January 19, 2017 ... global market for cryotherapy is set to witness a CAGR of ... North America will continue to be the leading ... ... Suppliers are emphasizing on ensuring affordable and adequate supply ...
(Date:1/19/2017)... Fla. , Jan. 19, 2017  Sensus ... medical device company specializing in the treatment of ... as keloids, with superficial radiation therapy, today announced ... full year 2016 financial results on Thursday, February 2, ... Company will hold a conference call with the ...
Breaking Medicine Technology: